Oncomfort is a Belgian company introducing the first European medical device which combines Clinical Hypnosis and Virtual Reality to help patients reducing their anxiety and pain.
Oncomfort provides evidence-based anxiety and pain self management modules to improve patients comfort throughout medical journey using virtual reality.
Oncomfort was founded in 2017 by Diane Jooris, Gérald de Patoul, Mario Huyghe, and Julien Tesse. The company is headquartered in Wavre, Wallonia, Belgium.
Oncomfort has invented Digital Sedation™, a completely new method for relieving patients' pain and anxiety through treatment with clinically proven sessions of therapeutic Virtual Reality. It combines Virtual Reality capabilities and knowledge on clinical hypnosis into an innovative medical solution for digital sedation.
Since the launch of the Sedakit™ for Digital Sedation™ in Benelux and France in June 2019, over 30,000 patients have been treated and have had their pain and anxiety relieved before, during, and after interventions in many clinical fields such as anesthesia, oncology, interventional radiology and cardiology, as well as pediatrics.
Oncomfort has raised €10M in a Series A funding round on Sep 09, 2020. The investment was co-led by Debiopharm and Crédit Mutuel Innovation.